Delivery Order SPE2DB20D2014-SPE2DB26FA17R
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitively awarded, non-set-aside delivery order carries a ceiling value of $32,930.62 under firm fixed-price terms, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,855.50 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a pharmaceutical delivery to support federal medical procurement needs. The work is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials, with a contract ceiling value of $43,208.69. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a routine pharmaceutical procurement under a competitively awarded, non-set-aside contract vehicle. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $4,893.47 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials. This non-competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.94 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. The order was competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price transaction with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.98 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 26, 2025. The award was issued on September 25, 2025, and the pharmaceutical will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,495.46 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The pharmaceutical products will be sourced and delivered from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $35.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens (3mL) with a firm fixed price and completion deadline of September 15, 2025. This is a competitively awarded contract with no set-aside designation, issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.3K to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This competitively awarded, non-set-aside contract was executed on April 28, 2025, with an ultimate completion date of April 29, 2025, and is priced on a firm fixed-price basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA17RDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,960.56 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This non-set-aside, competitively awarded contract utilizing firm fixed price terms represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery order falls within AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX and running through December 2026), which serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent award of non-set-aside, competitively awarded delivery orders demonstrates its capability to meet federal procurement standards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 10/23/25 |